BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6380269)

  • 1. Dipeptidylaminopeptidase IV activity in normal and leukemic T-cell subpopulations.
    Crockard AD; MacFarlane E; Andrews C; Bridges JM; Catovsky D
    Am J Clin Pathol; 1984 Sep; 82(3):294-9. PubMed ID: 6380269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidylaminopeptidase IV (DAP IV) activity in normal and malignant T-cell subsets as defined by monoclonal antibodies.
    Wirthmüller R; Dennig D; Oertel J; Gerhartz H
    Scand J Haematol; 1983 Sep; 31(3):197-205. PubMed ID: 6192484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymecytochemical heterogeneity of human chronic T-lymphocytic leukemia as demonstrated by reactivity to dipeptidylaminopeptidase IV (DAP IV; EC 3.4.14.4).
    Feller AC; Parwaresch MR; Bartels H; Lennert K
    Leuk Res; 1982; 6(6):801-8. PubMed ID: 6759796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidylaminopeptidase IV (DAP IV) in B- and T-cell leukaemias.
    Andrews C; Crockard AD; San Miguel JF; Catovsky D
    Clin Lab Haematol; 1985; 7(4):359-68. PubMed ID: 2869856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtyping of chronic lymphocytic leukemia of T-type by dipeptidylaminopeptidase IV (DAP IV), monoclonal antibodies, and Fc-receptors.
    Feller AC; Parwaresch MR; Lennert K
    Cancer; 1983 Nov; 52(9):1609-12. PubMed ID: 6137274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous expression of dipeptidyl-amino-peptidase (DAP IV) in T-cell chronic lymphocytic leukemia.
    Chilosi M; Pizzolo G; Semenzato G; de Rossi G; Pandolfi F
    Acta Haematol; 1984; 71(4):277-81. PubMed ID: 6426241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochemical distribution of dipeptidylaminopeptidase IV (DAP IV; EC-3.4.14.5) in T-lymphoblastic lymphoma/leukemia characterized with monoclonal antibodies.
    Feller AC; Parwaresch MR; Lennert K
    Leuk Res; 1984; 8(3):397-406. PubMed ID: 6379309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of dipeptidylaminopeptidase-IV in some human T and B cell lines.
    Srivastava MD; Bhargava AK
    Acta Haematol; 1986; 76(1):25-8. PubMed ID: 2878556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dipeptidyl aminopeptidase-IV in lymphocytes of patients with lymphoproliferative diseases].
    Bylinkina VS; Golubeva NV; Gureeva TA; Lokshina LA; Polianskaia AM; Samoĭlova RS
    Biull Eksp Biol Med; 1989 Jul; 108(7):85-8. PubMed ID: 2572281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochemistry of dipeptidylaminopeptidase IV and II in normal and neoplastic lymphoid cells.
    Invernizzi R; Bertolino G; Girino M; Perseghin P; Michienzi M; Nano R
    Blut; 1985 May; 50(5):277-85. PubMed ID: 2859898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase IV and alpha-naphthylacetate esterase in human T lymphocytes: cytochemical and biochemical investigations.
    Schön E; Ittenson A; Klemm K; Ansorge S
    Acta Histochem; 1984; 75(2):175-82. PubMed ID: 6151772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cytochemical study of dipeptidyl aminopeptidase (DAP) II and IV in normal and malignant haemic cells.
    Khalaf MR; Bevan PC; Hayhoe FG
    J Clin Pathol; 1986 Aug; 39(8):891-6. PubMed ID: 2875085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochemistry of normal lymphocyte subsets defined by monoclonal antibodies and immunocolloidal gold.
    Crockard A; Catovsky D
    Scand J Haematol; 1983 May; 30(5):433-43. PubMed ID: 6222467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl-amino-peptidase IV (DAP IV) activity in human T-cell subsets.
    Dufer J; Bernard J
    Acta Haematol; 1984; 72(3):213-4. PubMed ID: 6438989
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytochemical reactivity of T mu lymphocytes in human lymphatic tissue for dipeptidylaminopeptidase IV.
    Feller AC
    Histochem J; 1982 Nov; 14(6):889-95. PubMed ID: 6757193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic heterogeneity of leukemic Sézary cells.
    Feller AC; Ziegler A; Sterry W; Goos M; Parwaresch MR
    Blut; 1983 Dec; 47(6):333-41. PubMed ID: 6606455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid hydrolase activities in B cell chronic lymphocytic leukaemia lymphocytes: correlation of cytochemical reactions with immunological phenotype.
    Crockard AD; Macfarlane E; Markey GM; McConnell RE; Alexander HD; Agnew AN; Morris TC; Bridges JM
    Scand J Haematol; 1985 Mar; 34(3):242-50. PubMed ID: 2859652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidylaminopeptidase IV activity in T lymphocyte subsets in B cell non-Hodgkin's lymphomas.
    Cozzi M; Gloghini A; Sulfaro S; Volpe R; Carbone A
    Hum Pathol; 1989 Oct; 20(10):987-93. PubMed ID: 2571558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl(amino)peptidase IV (DAP-IV) histochemistry on normal and pathologic lymphoid tissues.
    Chilosi M; Pizzolo G; Menestrina F; Iannucci AM; Bonetti F; Fiore-Donati L
    Am J Clin Pathol; 1982 Jun; 77(6):714-9. PubMed ID: 7046417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistocytochemical correlation of DAP IV-CD 26 reactivity with immunologic markers of lymphocyte activation in human lymphoid tissues.
    Cozzi M; Gloghini A; Volpe R; Carbone A
    Br J Haematol; 1990 Jul; 75(3):325-32. PubMed ID: 1974815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.